Early cellular events in multiple sclerosis. Intimations of an extrinsic myelinolytic antigen

Frederick W Gay1

  • 1Cambridge Biostability, NIAB, Huntington Road, Cambridge CB3 OLE, UK. fwg@greenstorthe.freeserve.co.uk

Insights

Early multiple sclerosis (MS) involves inflammation in perivascular spaces, leading to myelin sheath damage. A diffusing antigen in cerebrospinal fluid may drive this early demyelination process.

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Previous studies identified five stages of demyelination in early multiple sclerosis (MS).
  • Early MS cases show inflammation in perivascular spaces affecting intact myelin sheaths.

Purpose of the Study:

  • To investigate the initial inflammatory events and cellular responses in early multiple sclerosis.
  • To characterize the nature and distribution of pathological changes in normal-appearing white and grey matter in early MS.

Main Methods:

  • Immunohistological analysis of brain tissues from early multiple sclerosis cases.
  • Cluster analysis to identify distinct stages of demyelination.
  • Examination of inflammatory markers, including HLA Class II antigens, complement (C3), immunoglobulins (IgG), and cellular infiltrates (CD4+ T cells).

Main Results:

  • Inflammatory events were concentrated in perivascular spaces, extending into parenchyma and affecting myelin sheaths.
  • Early lesions showed myelin sheath lysis, phagocytosis, HLA Class II expression on microglia, and C3-IgG complexes.
  • Parenchymal lesions had few CD4+ T cells and no plasma protein leakage, suggesting a localized inflammatory process.

Conclusions:

  • Early MS involves a diffusing, complement-fixing, myelinolytic antigen processed in perivascular spaces.
  • This antigen is distributed in cerebrospinal and extracellular fluids, initiating demyelination.
  • The findings suggest a unique pathogenic mechanism distinct from typical antibody-mediated demyelination.